Evidence map›Paper›PMID 31674011›Full record

ArticleThe Journal of pathology2020

Prostate epithelial-specific expression of activated PI3K drives stromal collagen production and accumulation.

Kyle A Wegner, Brett R Mueller, Christopher J Unterberger, Enrique J Avila, Hannah Ruetten, Anne E Turco, Steven R Oakes, Nicholas M Girardi, Richard B Halberg, Steven M Swanson and 2 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Mechanisms of prostatic inflammation-mediated male lower urinary tract symptoms.American journal of clinical and experimental urology · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kyle A WegnerMolecular and Environmental Toxicology Center, University of Wisconsin-Madison, Madison, WI, USA.
Brett R MuellerUniversity of Wisconsin-Madison/UMASS Boston George M. O'Brien Center for Benign Urologic Research, Madison, WI, USA.
Christopher J UnterbergerUniversity of Wisconsin-Madison/UMASS Boston George M. O'Brien Center for Benign Urologic Research, Madison, WI, USA.
Enrique J AvilaUniversity of Wisconsin-Madison/UMASS Boston George M. O'Brien Center for Benign Urologic Research, Madison, WI, USA.
Hannah RuettenDepartment of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA.
Anne E TurcoMolecular and Environmental Toxicology Center, University of Wisconsin-Madison, Madison, WI, USA.
Steven R OakesDepartment of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA.
Nicholas M GirardiDepartment of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI, USA.
Richard B HalbergDepartment of Oncology, McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, USA.
Steven M SwansonSchool of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA.
Paul C MarkerUniversity of Wisconsin-Madison/UMASS Boston George M. O'Brien Center for Benign Urologic Research, Madison, WI, USA.
Chad M VezinaMolecular and Environmental Toxicology Center, University of Wisconsin-Madison, Madison, WI, USA.ORCID 0000-0001-7058-5399
University of Wisconsin System · USUniversity of Wisconsin–Madison · US

Funding

Role of Beta-Catenin in Urinary DysfunctionU54DK104310 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI MACOSKA, JILL A., MARKER, PAUL C · 2014 to 2023
$12.8M
Molecular & Environmental Toxicology Pre-& Postdoctoral Training ProgramT32ES007015 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI CHRISTOPHER A BRADFIELD · 1985 to 2026
$11.5M
NRSA Training CoreTL1TR002375 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI Vivek Prabhakaran · 2017 to 2026
$8.4M
REPRODUCTIVE AND DEVELOPMENTAL TOXICITY OF DIOXINR01ES001332 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI PETERSON, RICHARD EUGENE, VEZINA, CHAD M. · 1985 to 2021
$5.3M
Magi2 in aggressive prostate cancerR21CA195313 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI MARKER, PAUL C · 2016 to 2017
$357k
Prostate inflammation increases collagen and voiding dysfunctionF30DK122686 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI RUETTEN, HANNAH MARGARET · 2019 to 2022
$157k
TCDD Reprograms Prostate Stroma and Causes Fibrosis to Induce Urinary DysfunctionF31ES028594 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI WEGNER, KYLE ALLEN · 2018 to 2019
$54k
Developmental origins of prostate-related urinary dysfunction in adult males: TCDD exposure increases prostatic noradrenergic innervation and smooth muscle contractionF31ES030968 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI TURCO, ANNE · 2020 to 2021
$42k
NCATS NIH HHS TL1 TR002375NCI NIH HHS R21 CA195313NIDDK NIH HHS F30 DK122686NIDDK NIH HHS U54 DK104310NIEHS NIH HHS F31 ES028594NIEHS NIH HHS F31 ES030968NIEHS NIH HHS R01 ES001332NIEHS NIH HHS T32 ES007015NIH HHS CA195313NIH HHS F30DK122686NIH HHS F31ES028594NIH HHS R01ES001332NIH HHS T32ES007015NIH HHS TL1TR002375NIH HHS U54DK104310NIH HHS U54DK104310S1
6 · The paper itself

Abstract

We genetically engineered expression of an activated form of P110 alpha, the catalytic subunit of PI3K, in mouse prostate epithelium to create a mouse model of direct PI3K activation (Pbsn-cre4Prb;PI3K

Indexed as

AgingAnimalsClass I Phosphatidylinositol 3-KinasesCollagenDisease Models, AnimalDisease ProgressionEpitheliumMaleMice, Mutant StrainsPhosphorylationProstateProstatic HyperplasiaProstatic Intraepithelial NeoplasiaProstatic NeoplasmsSignal TransductionSmad2 Protein1-phosphatidylinositol 3-kinase p110 subunit, mouseClass I Phosphatidylinositol 3-KinasesCollagenSmad2 ProteinSmad2 protein, mouseTransforming Growth Factor betacancercollagenfibrosismouse modelPIK3CAprostatestroma

Identifiers

PMID31674011
PMCPMC7071816
OpenAlexW2984008289

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.